Back
Cytokinetics Quote, Financials, Valuation and Earnings
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
37
CYTK
Cytokinetics
Last Price:
47.66
Seasonality Move:
14.49%
7 Day Trial
ALL ACCESS PASS
$
7
Access The Stock Grader Trading Tool From "The King Of Quants"
More details here...Cytokinetics Price Quote
$47.66
-0.01 (-4.41%)
(Updated: November 22, 2024 at 5:20 AM ET)
Cytokinetics Key Stats
Sell
37
Cytokinetics (CYTK)
is a Sell
Day range:
$47.56 - $50.45
52-week range:
$30.68 - $110.25
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1,584.36
P/B ratio:
0%
Volume:
1.8M
Avg. volume:
1.2M
1-year change:
50.19%
Market cap:
$5.6B
Revenue:
$7.5M
EPS:
$-5.38
How Much Does Cytokinetics Make?
-
How Much Are Cytokinetics's Sales Annually?
CYTK Revenues are $7.5M -
How Much Profit Does Cytokinetics's Make A Year?
CYTK net income is -$526.2M
Is Cytokinetics Growing As A Company?
-
What Is Cytokinetics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.22% -
What Is Cytokinetics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Cytokinetics Stock Price Performance
-
Did Cytokinetics Stock Go Up Last Month?
Cytokinetics share price went down by -11.41% last month -
Did CYTK's Share Price Rise Over The Last Year?
CYTK share price rose by 50.19% over the past 1 year
What Is Cytokinetics 52-Week High & Low?
-
What Is Cytokinetics’s 52-Week High Share Price?
Cytokinetics has traded as high as $110.25 over the past 52 weeks -
What Is Cytokinetics’s 52-Week Low Share Price?
Cytokinetics has traded as low as $30.68 over the past 52 weeks
Cytokinetics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Cytokinetics?
-
How Much Debt Does Cytokinetics Have?
Total long term debt quarterly is $656M -
How Much Cash Does Cytokinetics Have?
Cash and short term investments quarterly total is $1B -
What Is Cytokinetics’s Book Value Per Share?
Book value per share is -0.12
Is Cytokinetics Cash Flow Positive?
-
What Is CYTK Cash Flow From Operations?
Cash flow from operations (TTM) is -$404.4M -
What Is Cytokinetics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $1.1B -
What Is Cytokinetics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$745.4M
Cytokinetics Return On Invested Capital
-
Is Management Doing A Good Job?
CYTK return on invested capital is -142.05% -
What Is Cytokinetics Return On Assets?
ROA measures how assets are converting to revenues and is -54.04% -
What Is CYTK Return On Equity?
ROE is a measure of profitability and is 0%
Cytokinetics Earnings Date & Stock Price
-
What Is Cytokinetics's Stock Price Today?
A single share of CYTK can be purchased today for 47.67 -
What Is Cytokinetics’s Stock Symbol?
Cytokinetics trades on the nasdaq under the ticker symbol: CYTK -
When Is Cytokinetics’s Next Earnings Date?
The next quarterly earnings date for Cytokinetics is scheduled on February 27, 2025 -
When Is CYTK's next ex-dividend date?
Cytokinetics's next ex-dividend date is November 22, 2024 -
How To Buy Cytokinetics Stock?
You can buy Cytokinetics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Cytokinetics Competitors
-
Who Are Cytokinetics's Competitors?
Below is a list of companies who compete with Cytokinetics or are related in some way:
Cytokinetics Dividend Yield
-
What Is CYTK Dividend Yield?
Cytokinetics’s dividend yield currently is 0% -
What Is Cytokinetics’s Payout Ratio?
Cytokinetics’s payout ratio is 0% -
When Did Cytokinetics Last Pay A Dividend?
The latest dividend pay date is November 22, 2024 -
What Is Cytokinetics’s Dividend Per Share?
Cytokinetics pays a dividend of $0.00 per share
Cytokinetics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -9.26% |
| Revenue: | 22.49% | -60.77% |
Analyst Recommendations
| Buy Recommendations: | 7 |
|---|---|
| Hold Recommendations: | 4 |
| Sell Recommendations: | 0 |
| Price Target: | 81.41 |
| Upside from Last Price: | 70.78% |